CareDx PE Ratio 2013-2025 | CDNA
Current and historical p/e ratio for CareDx (CDNA) from 2013 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. CareDx PE ratio as of August 12, 2025 is 12.22.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| CareDx PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-08-13 | 12.13 | 10.55 | |
| 2025-03-31 | 17.75 | $1.15 | 15.43 |
| 2024-12-31 | 21.41 | $1.02 | 20.99 |
| 2024-09-30 | 31.23 | $-2.70 | 0.00 |
| 2024-06-30 | 15.53 | $-2.99 | 0.00 |
| 2024-03-31 | 10.59 | $-3.42 | 0.00 |
| 2023-12-31 | 12.00 | $-3.54 | 0.00 |
| 2023-09-30 | 7.00 | $-1.67 | 0.00 |
| 2023-06-30 | 8.50 | $-1.56 | 0.00 |
| 2023-03-31 | 9.14 | $-1.51 | 0.00 |
| 2022-12-31 | 11.41 | $-1.44 | 0.00 |
| 2022-09-30 | 17.02 | $-1.41 | 0.00 |
| 2022-06-30 | 21.48 | $-1.32 | 0.00 |
| 2022-03-31 | 36.99 | $-0.95 | 0.00 |
| 2021-12-31 | 45.48 | $-0.59 | 0.00 |
| 2021-09-30 | 63.37 | $-0.35 | 0.00 |
| 2021-06-30 | 91.52 | $-0.18 | 0.00 |
| 2021-03-31 | 68.09 | $-0.29 | 0.00 |
| 2020-12-31 | 72.45 | $-0.42 | 0.00 |
| 2020-09-30 | 37.94 | $-0.46 | 0.00 |
| 2020-06-30 | 35.43 | $-0.44 | 0.00 |
| 2020-03-31 | 21.83 | $-0.48 | 0.00 |
| 2019-12-31 | 21.57 | $-0.52 | 0.00 |
| 2019-09-30 | 22.61 | $-0.50 | 0.00 |
| 2019-06-30 | 35.99 | $-1.00 | 0.00 |
| 2019-03-31 | 31.52 | $-1.21 | 0.00 |
| 2018-12-31 | 25.14 | $-1.33 | 0.00 |
| 2018-09-30 | 28.85 | $-2.37 | 0.00 |
| 2018-06-30 | 12.24 | $-2.46 | 0.00 |
| 2018-03-31 | 7.97 | $-2.25 | 0.00 |
| 2017-12-31 | 7.34 | $-2.21 | 0.00 |
| 2017-09-30 | 3.70 | $-1.81 | 0.00 |
| 2017-06-30 | 1.11 | $-1.44 | 0.00 |
| 2017-03-31 | 1.40 | $-2.01 | 0.00 |
| 2016-12-31 | 2.70 | $-2.56 | 0.00 |
| 2016-09-30 | 3.55 | $-2.23 | 0.00 |
| 2016-06-30 | 4.31 | $-2.26 | 0.00 |
| 2016-03-31 | 4.96 | $-1.77 | 0.00 |
| 2015-12-31 | 6.40 | $-1.15 | 0.00 |
| 2015-09-30 | 4.17 | $-0.75 | 0.00 |
| 2015-06-30 | 6.50 | $-0.34 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.663B | $0.334B |
| CareDx, Inc. is a commercial stage company. It develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients. The Company provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients. It is also pursuing other areas of transplant surveillance, such as the use of cell-free DNA (cfDNA) as a biomarker for rejection. CareDx, Inc. is based in Brisbane, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $147.306B | 27.32 |
| CVS Health (CVS) | United States | $83.088B | 10.33 |
| Elevance Health (ELV) | United States | $65.860B | 8.86 |
| Cencora (COR) | United States | $56.044B | 18.67 |
| DiDi Global (DIDIY) | China | $26.733B | 28.40 |
| Labcorp Holdings (LH) | United States | $22.380B | 17.79 |
| Natera (NTRA) | United States | $21.934B | 0.00 |
| BioMerieux (BMXMF) | France | $17.238B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.271B | 0.00 |
| ICON (ICLR) | Ireland | $13.654B | 13.14 |
| CochLear (CHEOY) | Australia | $13.302B | 0.00 |
| Medpace Holdings (MEDP) | United States | $12.903B | 34.15 |
| Solventum (SOLV) | United States | $12.500B | 12.90 |
| Viatris (VTRS) | United States | $11.799B | 4.20 |
| Revvity (RVTY) | United States | $10.214B | 18.00 |
| Sonic Healthcare (SKHHY) | Australia | $9.176B | 0.00 |
| Avantor (AVTR) | United States | $8.631B | 12.66 |
| Caris Life Sciences,�Inc (CAI) | United States | $8.258B | 0.00 |
| HealthEquity (HQY) | United States | $8.040B | 35.22 |
| Charles River Laboratories (CRL) | United States | $7.517B | 14.26 |
| Bausch + Lomb (BLCO) | Canada | $4.874B | 32.79 |
| Sotera Health (SHC) | United States | $4.221B | 23.59 |
| Amplifon S.p.A (AMFPF) | Italy | $3.937B | 21.83 |
| BrightSpring Health Services (BTSG) | United States | $3.848B | 29.35 |
| GeneDx Holdings (WGS) | United States | $3.344B | 76.59 |
| Surgery Partners (SGRY) | United States | $2.946B | 37.06 |
| Alignment Healthcare (ALHC) | United States | $2.899B | 0.00 |
| Concentras Parent (CON) | United States | $2.871B | 18.21 |
| Organon (OGN) | United States | $2.353B | 2.56 |
| Premier (PINC) | United States | $1.978B | 15.01 |
| Progyny (PGNY) | United States | $1.873B | 39.60 |
| Ardent Health (ARDT) | United States | $1.785B | 6.89 |
| PACS (PACS) | United States | $1.705B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.282B | 8.56 |
| GoodRx Holdings (GDRX) | United States | $1.250B | 20.59 |
| Teladoc Health (TDOC) | United States | $1.214B | 0.00 |
| Establishment Labs Holdings (ESTA) | $0.974B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.965B | 0.00 |
| Embecta (EMBC) | United States | $0.779B | 4.56 |
| AMN Healthcare Services Inc (AMN) | United States | $0.676B | 8.36 |
| Performant Healthcare (PHLT) | United States | $0.602B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.583B | 200.00 |
| Nutex Health (NUTX) | United States | $0.534B | 8.08 |
| Omada Health (OMDA) | $0.497B | 0.00 | |
| So-Young (SY) | China | $0.488B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.485B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.480B | 0.00 |
| SBC Medicals (SBC) | United States | $0.470B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.467B | 10.52 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.405B | 0.00 |
| Enhabit (EHAB) | United States | $0.382B | 25.13 |
| Agilon Health (AGL) | United States | $0.369B | 0.00 |
| Oncology Institute (TOI) | United States | $0.367B | 0.00 |
| LifeMD (LFMD) | United States | $0.324B | 0.00 |
| Beauty Health (SKIN) | United States | $0.292B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.200B | 0.00 |
| DocGo (DCGO) | United States | $0.169B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.129B | 0.00 |
| KindlyMD (NAKA) | United States | $0.084B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.084B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| Biodesix (BDSX) | United States | $0.060B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.048B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.040B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.040B | 0.00 |
| ModivCare (MODV) | United States | $0.033B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.011B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.010B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |